4
Registered trials
2
Recruiting
4
Unique sponsors
3
Unique IMPs
3
Commercial trials
Drug classes (ATC)
—
ATC code not specified
3
J
Anti-infectives (ATC J)
1
Mechanism of action (INN-stem analysis)
Unknown / small molecule
3 substances
Phase III:
2
Phase II/III:
1
Phase I:
1
Phase III
2 trials-
EndedAstellas Pharma Global Development Inc. CommercialMIRABEGRON
-
RecruitingCentre Hospitalier Universitaire De Dijon AcademicE.COLI POLYSACCHARIDE
Phase II/III
1 trial-
RecruitingSumitomo Pharma America Inc. CommercialVIBEGRON
Phase I
1 trial-
PendingPhagenix CommercialIMP not specified
Sponsor activity
| Sponsor | Type | Trials | Phases | Recruiting |
|---|---|---|---|---|
| Phagenix | Commercial | 1 | Phase I | 0 |
| Sumitomo Pharma America Inc. | Commercial | 1 | Phase II/III | 1 |
| Astellas Pharma Global Development Inc. | Commercial | 1 | Phase III | 0 |
| Centre Hospitalier Universitaire De Dijon | Academic | 1 | Phase III | 1 |
New trials by year
2023
1
2024
2